AiRato Inc. is a pioneering Japanese startup dedicated to advancing radiation therapy through artificial intelligence. Their flagship product, AIVOT, is designed to enhance the quality and efficiency of radiation treatment planning, aiming to improve patient outcomes and streamline clinical workflows.
Key Features and Functionality:
- RatoCheck: This software performs double-checks (QA) on radiation therapy plans created with Treatment Planning Systems (TPS). It calculates reference dose distributions, gamma pass rates, and complexity indices to ensure plan accuracy and safety.
- RatoGuide: An AI-based tool that automates various processes in intensity-modulated radiation therapy (IMRT), including automatic contouring and treatment planning. It supports multiple cancer types and employs deep learning to generate high-quality treatment plans.
- RatoAnonymizer: A free software that anonymizes DICOM files by removing or replacing personal information, facilitating secure secondary use of medical data.
Primary Value and Solutions:
AiRato's suite of AI-driven tools addresses several critical challenges in radiation therapy:
- Quality Assurance: By automating the QA process, RatoCheck ensures consistent and accurate treatment plans, reducing variability due to human factors.
- Efficiency: RatoGuide significantly reduces the time required for treatment planning, allowing clinicians to focus more on patient care.
- Data Security: RatoAnonymizer enables the safe sharing and analysis of medical data by protecting patient privacy, which is essential for research and collaborative efforts.
Through these innovations, AiRato aims to make radiation therapy more accessible, efficient, and effective, ultimately improving the quality of life for cancer patients.
